published meta-analysis   sensitivity analysis   studies

standard of care in COVID 19 all comers - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsNOR-Solidarity (hydroxychloroquine), 2021 (REV) 0.32 [0.03; 3.45] 0.32[0.03; 3.45]NOR-Solidarity (hydroxychloroquine), 2021 (REV)10%112NAnot evaluable deaths (time to event analysis only)detailed resultsNOR-Solidarity (hydroxychloroquine), 2021 (REV) 0.32 [0.03; 3.45] 0.32[0.03; 3.45]NOR-Solidarity (hydroxychloroquine), 2021 (REV)10%112NAnot evaluable0.22.01.0relative treatment effectwww.metaEvidence.org2024-05-14 22:24 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 94 - treatments: 651 - roots T: 651